1 31/03/2024 2024-03-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-04-01 Sage Accounts Production 23.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 13631064 2023-04-01 2024-03-31 13631064 2024-03-31 13631064 2023-03-31 13631064 2022-04-01 2023-03-31 13631064 2023-03-31 13631064 2022-03-31 13631064 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 13631064 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 13631064 bus:OrdinaryShareClass3 2023-04-01 2024-03-31 13631064 bus:OrdinaryShareClass4 2023-04-01 2024-03-31 13631064 bus:Director1 2023-04-01 2024-03-31 13631064 core:MotorVehicles 2023-03-31 13631064 core:FurnitureFittingsToolsEquipment 2024-03-31 13631064 core:MotorVehicles 2024-03-31 13631064 core:WithinOneYear 2024-03-31 13631064 core:WithinOneYear 2023-03-31 13631064 core:ShareCapital 2024-03-31 13631064 core:ShareCapital 2023-03-31 13631064 core:RetainedEarningsAccumulatedLosses 2024-03-31 13631064 core:RetainedEarningsAccumulatedLosses 2023-03-31 13631064 bus:OrdinaryShareClass1 core:ShareCapital 2024-03-31 13631064 bus:OrdinaryShareClass1 core:ShareCapital 2023-03-31 13631064 bus:OrdinaryShareClass2 core:ShareCapital 2024-03-31 13631064 bus:OrdinaryShareClass2 core:ShareCapital 2023-03-31 13631064 bus:OrdinaryShareClass3 core:ShareCapital 2024-03-31 13631064 bus:OrdinaryShareClass3 core:ShareCapital 2023-03-31 13631064 bus:OrdinaryShareClass4 core:ShareCapital 2024-03-31 13631064 bus:OrdinaryShareClass4 core:ShareCapital 2023-03-31 13631064 core:DeferredTaxation 2023-04-01 2024-03-31 13631064 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 13631064 core:MotorVehicles 2023-04-01 2024-03-31 13631064 core:AcceleratedTaxDepreciationDeferredTax 2024-03-31 13631064 core:AcceleratedTaxDepreciationDeferredTax 2023-03-31 13631064 core:MotorVehicles 2023-03-31 13631064 core:DeferredTaxation 2023-03-31 13631064 core:DeferredTaxation 2024-03-31 13631064 bus:SmallEntities 2023-04-01 2024-03-31 13631064 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 13631064 bus:FullAccounts 2023-04-01 2024-03-31 13631064 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 13631064 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31
Company registration number: 13631064
Rosaleesa Healthcare Ltd
Unaudited filleted financial statements
31 March 2024
Rosaleesa Healthcare Ltd
Contents
Balance sheet
Notes to the financial statements
Rosaleesa Healthcare Ltd
Balance sheet
31 March 2024
31/03/24 31/03/23
Note £ £ £ £
Fixed assets
Tangible assets 5 46,000 55,090
_______ _______
46,000 55,090
Current assets
Debtors 6 46,198 36,995
Cash at bank and in hand 53,654 9,120
_______ _______
99,852 46,115
Creditors: amounts falling due
within one year 7 ( 78,002) ( 54,161)
_______ _______
Net current assets/(liabilities) 21,850 ( 8,046)
_______ _______
Total assets less current liabilities 67,850 47,044
Provisions for liabilities 8 ( 8,550) ( 10,467)
_______ _______
Net assets 59,300 36,577
_______ _______
Capital and reserves
Called up share capital 10 102 102
Profit and loss account 59,198 36,475
_______ _______
Shareholders funds 59,300 36,577
_______ _______
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the Profit and loss has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 02 September 2024 , and are signed on behalf of the board by:
Mr Sateesh Gokhale
Director
Company registration number: 13631064
Rosaleesa Healthcare Ltd
Notes to the financial statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in United Kingdom. The address of the registered office is Rosaleesa Healthcare ltd, Clifton House, Four Elms Road, Cardiff, CF24 1LE.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the Balance sheet and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. All of the financial instruments applying to the company are basic as defined in the Accounting Standard, and as such are initially recognised at the transactions price. Debt instruments are subsequently measured at amortised costs.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
5. Tangible assets
Fixtures, fittings and equipment Motor vehicles Total
£ £ £
Cost
At 1 April 2023 - 55,090 55,090
Additions 6,297 - 6,297
_______ _______ _______
At 31 March 2024 6,297 55,090 61,387
_______ _______ _______
Depreciation
At 1 April 2023 - - -
Charge for the year 1,597 13,790 15,387
_______ _______ _______
At 31 March 2024 1,597 13,790 15,387
_______ _______ _______
Carrying amount
At 31 March 2024 4,700 41,300 46,000
_______ _______ _______
At 31 March 2023 - 55,090 55,090
_______ _______ _______
6. Debtors
31/03/24 31/03/23
£ £
Trade debtors 46,196 33,035
Other debtors 2 3,960
_______ _______
46,198 36,995
_______ _______
7. Creditors: amounts falling due within one year
31/03/24 31/03/23
£ £
Social security and other taxes 7,517 -
Director loan accounts 68,505 52,721
_______ _______
78,002 54,161
_______ _______
8. Provisions
Deferred tax (note 9) Total
£ £
At 1 April 2023 10,467 10,467
Charges against provisions ( 1,917) ( 1,917)
_______ _______
At 31 March 2024 8,550 8,550
_______ _______
9. Deferred tax
The deferred tax included in the Balance sheet is as follows:
31/03/24 31/03/23
£ £
Included in provisions (note 8) 8,550 10,467
_______ _______
The deferred tax account consists of the tax effect of timing differences in respect of:
31/03/24 31/03/23
£ £
Accelerated capital allowances 8,550 10,467
_______ _______
10. Called up share capital
Issued, called up and fully paid
31/03/24 31/03/23
No £ No £
Ordinary Shares shares of £ 1.00 each 50 50 50 50
Ordinary A Shares shares of £ 1.00 each 50 50 50 50
Ordinary B Shares shares of £ 1.00 each 1 1 1 1
Ordinary C Shares shares of £ 1.00 each 1 1 1 1
_______ _______ _______ _______
102 102 102 102
_______ _______ _______ _______